lululemon (LULU) Q2 2026 earnings review
Growth Story Stalls as Turnaround Plan Falters
Lululemon's sales officially reversed into contraction in Q2, with revenue falling 4% and comparable sales plunging 9%. Most concerning is the contagion: weakness has spread from the Americas (comps down 12%) to previously resilient International markets, where comps fell 3%. While reported EPS of $2.92 appears passable, it is artificially inflated by a massive $0.86 per share one-time tariff refund. Stripping this out reveals a severe margin collapse. Management slashed full-year guidance to a 5-7% revenue decline and projects a dismal 10-11% drop in Q3. Incoming CEO Heidi O'Neill faces a daunting mandate to reset the product pipeline and repair brand heat.
🐂 Bull Case
Despite plunging sales, unit inventory decreased 7% year-over-year. This structural discipline prevents a massive, margin-crushing clearance event and keeps the floor clean for new product arrivals.
The company repurchased 2.7 million shares for $330 million, capitalizing on lower valuations. Supported by $1.4 billion in cash, aggressive buybacks will help cushion the EPS decline.
🐻 Bear Case
International sales grew just 4% with comps reversing to -3%. The global growth engine that was meant to buffer the North American turnaround has stalled abruptly.
A Q3 revenue guide of -10% to -11% indicates that current product launches are not resonating and negative brand momentum is accelerating heading into the critical holiday period.
⚖️ Verdict: 🔴🔴
Bearish. The core product engine is misfiring, margins are structurally deteriorating when adjusting for one-time tax/tariff windfalls, and the historical safety net of international growth has vanished.
Key Themes
Low-Quality Earnings Mask Real Profit Collapse
The reported EPS beat ($2.92) completely contradicts the narrative of a deteriorating business. Drilling into the data reveals a $134.5 million IEEPA tariff refund that provided a 560-basis-point benefit to margins and an $0.86 benefit to EPS. Excluding this windfall, adjusted gross margin compressed 360 basis points to 54.9%, and adjusted EPS was approximately $2.06—a severe ~33% year-over-year decline. The core profitability profile is breaking down under deleverage.
International Contagion
The most alarming data point in the Q2 release is the sudden deceleration in International markets. Previously the company's growth engine (+22% in Q1), International revenue decelerated violently to +4% in Q2, with comparable sales reversing to -3%. The brand fatigue and product staleness are no longer isolated to the Americas—it is now a synchronized global slowdown.
Inventory Discipline Remains Intact
Despite a massive top-line miss, inventory metrics remained disciplined. Total inventory value decreased 1% year-over-year, while unit inventory fell 7%. Management is successfully choking off supply to match plummeting demand, which will protect the brand from a disastrous, margin-eroding wave of promotional clearance.
New Leadership Catalyst & Product Reset
Incoming CEO Heidi O'Neill takes over a struggling enterprise next week. Her immediate mandate will be accelerating the '35% newness' product target. Past innovations like 'ThermoZen' and 'Unrestricted Power' were not enough to offset the failure of the 'new look of yoga' campaign and fatigue in core lounge franchises. Fixing this pipeline is the absolute primary driver for any future top-line recovery.
Macroeconomic & Sentiment Headwinds
Management continues to cite challenging macroeconomic dynamics and shifts in consumer sentiment. In previous quarters, 'spikes of negative commentary' damaged traffic. The staggering Q3 guidance implies these headwinds are intensifying, and consumers are fully rejecting premium pricing in the absence of compelling product newness.
Other KPIs
Accelerating significantly from $209.7 million in the first half of 2025. This 181% surge is primarily driven by strict working capital management—specifically, the sharp reduction in inventory purchases compared to the massive stock build-ups seen in the prior year.
The company repurchased 2.7 million shares during the quarter. This aggressive capital return strategy is utilizing the $1.39 billion cash pile to provide a slight mechanical floor to EPS while the operational turnaround stalls.
Guidance
Reversing violently. The midpoint implies a severe 10.5% year-over-year decline. This is a dramatic deceleration from Q2's 4% drop and signals that the product and brand issues will get materially worse before they get better.
Decelerating sharply. For context, Q3 2025 EPS was $2.59. The midpoint of $0.95 implies an approximate 63% year-over-year collapse in earnings, reflecting massive deleverage on fixed costs and anticipated investments to clear stalled products.
Reversing. The company slashed its full-year outlook from the previous expectation of $11.00B-$11.15B down to an implied 5% to 7% decline. This formalizes 2026 as a 'lost year' for the top line.
Decelerating. Lowered from the previous target of $10.95-$11.15. Keep in mind, this new range *includes* the $0.86 one-time tariff benefit from Q2. On an organic basis, the implied earnings erosion is devastating.
Key Questions
International Collapse
With International comps suddenly reversing to -3%, what specific regions or product categories drove this drop, and is it a direct result of the same negative brand commentary that stalled North America earlier this year?
Margin Floor in Q3
Given the massive Q3 EPS guide down to ~$0.95, how much of this contraction is driven by intentional, aggressive markdowns to clear the floors for the new CEO, versus pure top-line deleverage?
Product Pipeline Acceleration
As Heidi O'Neill takes over, will there be a structural change to the goal of reaching '35% newness' by Spring 2026, or can that timeline be accelerated to arrest the sales declines projected for the back half of the year?